India to Philippines: Cetirizine Export Trade Route
India has recorded 492 verified shipments of Cetirizine exported to Philippines, representing a combined trade value of $17.6M USD. This corridor is served by 74 active Indian exporters, with an average shipment value of $35.7K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 46% of total export value with 33 shipments worth $8.0M USD. On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer in Philippines with $2.9M USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, FREDUN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Cetirizine corridor is one of India's established pharmaceutical export routes, with 492 shipments documented worth a combined $17.6M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's cetirizine manufacturing sector.
Across 74 active suppliers, the average shipment value stands at $35.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with cetirizine's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 16.5%, placing it at rank #5 among India's top cetirizine export destinations globally.
On the import side, key buyers of Indian cetirizine in Philippines include AJANTA PHARMA PHILIPPINES INC, The Cathay Drug Co Inc, AMB HK ENTERPRISES INC. and 81 others. AJANTA PHARMA PHILIPPINES INC is the single largest importer with 20 shipments valued at $2.9M USD.
